Home Cart Sign in  
Chemical Structure| 141977-79-9 Chemical Structure| 141977-79-9

Structure of Miriplatin
CAS No.: 141977-79-9

Chemical Structure| 141977-79-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

Synonyms: SM-11355

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Miriplatin

CAS No. :141977-79-9
Formula : C34H68N2O4Pt
M.W : 763.99
SMILES Code : O=C(O[Pt]OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCCCC.N[C@H]1[C@@H](CCCC1)N
Synonyms :
SM-11355
MDL No. :MFCD04113190

Safety of Miriplatin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Miriplatin

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells 0.2 μg/ml To evaluate the cytotoxic effect of Miriplatin on HepG2 cells, results showed that Miriplatin significantly inhibited the proliferation of HepG2 cells. Asian J Pharm Sci. 2020 Nov;15(6):739-751
SU.86.86 0.1-25 μmol/L 24-48 h Evaluate the anti-proliferative effect of LMPt on pancreatic cancer cells, showing that LMPt exhibits significant anti-tumor activity in both GEM-sensitive and resistant cells Acta Pharm Sin B. 2023 Nov;13(11):4477-4501
PANC-1 0.1-25 μmol/L 24-48 h Evaluate the anti-proliferative effect of LMPt on pancreatic cancer cells, showing that LMPt exhibits significant anti-tumor activity in both GEM-sensitive and resistant cells Acta Pharm Sin B. 2023 Nov;13(11):4477-4501
MIA-PaCa-2 0.1-25 μmol/L 24-48 h Evaluate the anti-proliferative effect of LMPt on pancreatic cancer cells, showing that LMPt exhibits significant anti-tumor activity in both GEM-sensitive and resistant cells Acta Pharm Sin B. 2023 Nov;13(11):4477-4501
BxPC-3 0.1-25 μmol/L 24-48 h Evaluate the anti-proliferative effect of LMPt on pancreatic cancer cells, showing that LMPt exhibits significant anti-tumor activity in both GEM-sensitive and resistant cells Acta Pharm Sin B. 2023 Nov;13(11):4477-4501
AsPC-1 0.1-25 μmol/L 24-48 h Evaluate the anti-proliferative effect of LMPt on pancreatic cancer cells, showing that LMPt exhibits significant anti-tumor activity in both GEM-sensitive and resistant cells Acta Pharm Sin B. 2023 Nov;13(11):4477-4501

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice HepG2 xenograft tumor model Intratumoral injection 25 mg/kg Single dose, observed for 17 days To evaluate the antitumor effect of Miriplatin alone or in combination with REGO microspheres, results showed that combination therapy significantly enhanced the antitumor effect. Asian J Pharm Sci. 2020 Nov;15(6):739-751

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.31mL

0.26mL

0.13mL

6.54mL

1.31mL

0.65mL

13.09mL

2.62mL

1.31mL

References

 

Historical Records

Categories